Aug 2026· Molecular Therapy: Nucleic Acids· Vol 37, pp. 103077· 1 citation· 47 references
Medicine
TL;DR
Findings indicate that uORF-mediated repression of TTN is context-dependent and not recapitulated in a disease-relevant model, which highlights the complex regulation of TTN expression and the importance of validating regulatory elements in their endogenous context.
Abstract
Familial dilated cardiomyopathy (DCM) is a common condition with a high clinical burden, and no therapies that target the underlying genetic mechanisms. The leading genetic cause of DCM is heterozygous truncating variants in TTN, which are thought to drive disease through haploinsufficiency, where titin is reduced. This raises the possibility of treating disease through therapeutic upregulation of endogenous TTN expression. Upstream open reading frames (uORFs) are regulatory elements that repress translation and have been targeted to upregulate gene expression in a range of genes. Two uORFs in the TTN 5ʹ untranslated region have been shown to repress expression in luciferase reporter assays, suggesting potential for therapeutic targeting. Here, we investigated the role of TTN uORFs in reporter systems and in the endogenous locus in a human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) model. While disruption of uORFs increased expression in luciferase reporter gene assays, including in hiPSC-CMs, CRISPR-Cas9-mediated disruption of uORFs at the endogenous TTN locus in hiPSC-CMs did not increase titin protein expression. These findings indicate that uORF-mediated repression of TTN is context-dependent and not recapitulated in a disease-relevant model. This highlights the complex regulation of TTN expression and the importance of validating regulatory elements in their endogenous context.
It is shown that splice-switching ASOs can elicit target exon skipping and up-regulate endogenous protein levels, and it is shown that TSC1 uORFs act additively to reduce protein translation.
Eloise S. Beer Wells, L. De Conti, Hyung Chul Kim et al.· Genome Medicine· 0 citations
A model in which nuclear envelope rupture in cKO cardiomyocytes triggers cytosolic DNA sensing pathways and maladaptive cell-cell communication with fibroblasts and immune cells, driving inflammation, fibrosis, and cardiac dysfunction is supported.
Noam Zuela-Sopilniak, J. Morival, Ioannis Ntekas et al.· Circulation Research· 0 citations
This study uncovers a therapeutic vulnerable lncRNA-centric circuitry and provides compelling preclinical evidence for the development and application of a novel RNA targeting-LNP based therapy for treatment of myeloid leukemia.
Zhenggen Jin, Brendan D. Ma, Karen Y. T. Chan et al.· bioRxiv· 0 citations
Heterozygous loss-of-function variants causing gene dosage reduction underlie many human genetic disorders, yet preclinical mouse models frequently fail to recapitulate human disease phenotypes due to post-translational compensation. Here, we present a generalizable framework to modulate gene dosage by alternative spli...
Eric D. Smith, Joshua K. Meisner, Abbey Bullard et al.· bioRxiv· 0 citations
It is demonstrated that expanded DMPK transcript levels modulate free MBNL1 concentration and alternative splicing in a dose-dependent manner, underscoring the central role of repeat RNA expression in DM1 pathogenesis.
Lise Ripken, Thomas D. Hoekman, M. Willemse et al.· Human Molecular Genetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.